What they were paid
Cullinan Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | — | $0 | $214,995 | $0 | $214,995 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cullinan Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-183465, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Cullinan Therapeutics pays directors a $40,000 cash retainer and $215,000 in Options.
The rest of the Cullinan Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Allen, M.D., Ph.D | Independent Director | $377,326 |
| Anthony Rosenberg | Independent Director | $306,329 |
| David Meek | Independent Director | $268,639 |
| Mary Thistle | Independent Director | $57,000 |
| Mittie Doyle, M.D., FACR | Independent Director | $376,928 |
| Nadim Ahmed | Director | $0 |
| Stephen Webster | Independent Director | $280,995 |
The full Cullinan Therapeutics compensation record
free company briefThis page is one director within Cullinan Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat